Your browser doesn't support javascript.
loading
Prospective Investigation of Serum Metabolites, Coffee Drinking, Liver Cancer Incidence, and Liver Disease Mortality.
Loftfield, Erikka; Rothwell, Joseph A; Sinha, Rashmi; Keski-Rahkonen, Pekka; Robinot, Nivonirina; Albanes, Demetrius; Weinstein, Stephanie J; Derkach, Andriy; Sampson, Joshua; Scalbert, Augustin; Freedman, Neal D.
Afiliación
  • Loftfield E; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Rothwell JA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Sinha R; Nutrition and Metabolism Section, Biomarkers Group, International Agency for Research on Cancer, Lyon, France.
  • Keski-Rahkonen P; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Robinot N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Albanes D; Nutrition and Metabolism Section, Biomarkers Group, International Agency for Research on Cancer, Lyon, France.
  • Weinstein SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Derkach A; Nutrition and Metabolism Section, Biomarkers Group, International Agency for Research on Cancer, Lyon, France.
  • Sampson J; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Scalbert A; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Freedman ND; Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
J Natl Cancer Inst ; 112(3): 286-294, 2020 03 01.
Article en En | MEDLINE | ID: mdl-31168595
BACKGROUND: Coffee has been consistently associated with lower risk of liver cancer and chronic liver disease, suggesting that coffee affects mechanisms underlying disease development. METHODS: We measured serum metabolites using untargeted metabolomics in 1:1 matched nested case-control studies of liver cancer (n = 221 cases) and fatal liver disease (n = 242 cases) in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention cohort (n = 29 133). Associations between baseline coffee drinking and metabolites were identified using linear regression; conditional logistic regression models were used to identify associations with subsequent outcomes. RESULTS: Overall, 21 metabolites were associated with coffee drinking and also each subsequent endpoint; nine metabolites and trigonelline, a known coffee biomarker, were identified. Tyrosine and two bile acids, glycochenodeoxycholic acid (GCDCA) and glycocholic acid (GCA), were inversely associated with coffee but positively associated with both outcomes; odds ratios (ORs) comparing the 90th to 10th percentile (modeled on a continuous basis) ranged from 3.93 (95% confidence interval [CI] = 2.00 to 7.74) for tyrosine to 4.95 (95% CI = 2.64 to 9.29) for GCA and from 4.00 (95% CI = 2.42 to 6.62) for GCA to 6.77 (95% CI = 3.62 to 12.65) for GCDCA for liver cancer and fatal liver disease, respectively. The remaining six metabolites and trigonelline were positively associated with coffee drinking but inversely associated with both outcomes; odds ratio ranged from 0.16 to 0.37. Associations persisted following diet adjustment and for outcomes occurring greater than 10 years after blood collection. CONCLUSIONS: A broad range of compounds were associated with coffee drinking, incident liver cancer, and liver disease death over 27 years of follow-up. These associations provide novel insight into chronic liver disease and liver cancer etiology and support a possible hepatoprotective effect of coffee.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_digestive_diseases / 6_liver_cancer Asunto principal: Café / Hepatopatías / Neoplasias Hepáticas Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Natl Cancer Inst Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_digestive_diseases / 6_liver_cancer Asunto principal: Café / Hepatopatías / Neoplasias Hepáticas Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Natl Cancer Inst Año: 2020 Tipo del documento: Article
...